CME Kidney Disease Outcomes 
Cardiometabolic Health Congress
AUGUST 14, 2024
The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Chair: Erin D. Michos, MD Presenters: Chiadi Ndumele, MD; Pam R. Co-Presenters: Diana Barb, MD; Mitchell L.
Cardiometabolic Health Congress
JUNE 24, 2024
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.
Cardiometabolic Health Congress
JULY 25, 2024
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The future of care demands a holistic approach.
Cardiometabolic Health Congress
NOVEMBER 14, 2024
With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. cardiometabolic health CME/CE conference: the 19th Annual CMHC. In the U.S.,
Cardiometabolic Health Congress
DECEMBER 17, 2024
For healthcare providers, adopting an integrated, patient-centered approach is important for better outcomes. Research stresses the use of these pillars of therapy, highlighting that combinations of these agents can significantly reduce the progression of chronic kidney disease (CKD) and lower cardiovascular risks.
Expert insights. Personalized for you.
72 
Let's personalize your content